A383930 logo

DT&CRO CO., Ltd. Stock Price

KOSDAQ:A383930 Community·₩32.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A383930 Share Price Performance

₩0
-4710.00 (-100.00%)
₩0
-4710.00 (-100.00%)
Price ₩0

A383930 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk and slightly overvalued.

3 Risks
0 Rewards

DT&CRO CO., Ltd. Key Details

₩47.8b

Revenue

₩45.1b

Cost of Revenue

₩2.7b

Gross Profit

₩15.0b

Other Expenses

-₩12.3b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-960.68
5.59%
-25.71%
330.9%
View Full Analysis

About A383930

Founded
2017
Employees
n/a
CEO
n/a
WebsiteView website
www.dtncro.com

DT&CRO CO., Ltd. operates as a full-service CRO provider in South Korea. The company conducts a series of consigned studies ranging from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional food, cosmetics, and medical devices to analysis, bioactivity, clinical trials, and licensing consulting. DT&CRO CO., Ltd. was founded in 2017 and is based in Yongin-si, South Korea.

Recent A383930 News & Updates

Recent updates

No updates